Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Maxcyte, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 124 | 1 | 114 | −9 |
| Shares | 67.0M | 82.8K | 68.3M | +1.42M (+2.1%) |
| Value | $280.8M | $346.9K | $268.0M | −$12.5M (−4.4%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Maxcyte, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 499,669 | $1.96M | 0.00% |
| Corebridge Financial, Inc. | 56,288 | $220.6K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 43,929 | $172.2K | 0.00% |
| State Board of Administration of Florida Retirement System | 25,080 | $98.1K | 0.00% |
| Creative Planning | 21,440 | $84.0K | 0.00% |
| Verition Fund Management LLC | 15,290 | $59.9K | 0.00% |
| Ridgewood Investments LLC | 1,000 | $3.92K | 0.00% |
| Lindbrook Capital, LLC | 116 | $455 | 0.00% |
| Rothschild Investment LLC | 30 | $118 | 0.00% |
Sold out (18)
Institutions that held Maxcyte, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Allspring Global Investments Holdings, LLC | 285,146 | $1.19M |
| AWM Investment Company, Inc. | 121,724 | $510.0K |
| Alberta Investment Management Corp | 109,545 | $459.0K |
| Millrace Asset Group, Inc. | 84,043 | $352.0K |
| SEI Investments Co | 70,706 | $296.3K |
| Apis Capital Advisors, LLC | 45,800 | $191.9K |
| American International Group, Inc. | 43,071 | $180.5K |
| Sherbrooke Park Advisers LLC | 42,895 | $179.7K |
| Centiva Capital, LP | 36,591 | $153.3K |
| Two Sigma Advisers, LP | 27,400 | $114.8K |
| Qube Research & Technologies Ltd | 17,535 | $73.5K |
| AJOVista, LLC | 14,968 | $62.7K |
| State of Wyoming | 8,991 | $37.7K |
| EntryPoint Capital, LLC | 6,883 | $28.8K |
| Russell Investments Group, Ltd. | 6,700 | $28.1K |
| Metropolitan Life Insurance Co | 5,026 | $21.1K |
| Steward Partners Investment Advisory, LLC | 1,630 | $6.83K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 17 | $71 |
Not filed for Q2 2024 yet (1)
Institutions that held Maxcyte, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 82,801 | $346.9K |